Effect of hemodialysis on hepatic cytochrome P450 functional expression.
about
The serum 24,25-dihydroxyvitamin D concentration, a marker of vitamin D catabolism, is reduced in chronic kidney disease.CYP3A5 polymorphism affects the increase in CYP3A activity after living kidney transplantation in patients with end stage renal disease.Effects of uremic toxins on transport and metabolism of different biopharmaceutics drug disposition classification system xenobioticsImpaired vitamin D metabolism in CKDSignificant increase in plasma 4β-hydroxycholesterol concentration in patients after kidney transplantation.Antimicrobial dosing in acute renal replacement.Hemodialysis does not alter in vitro hepatic CYP3A4 and CYP2D6 metabolic activity in uremic serum.Antimicrobial dosing concepts and recommendations for critically ill adult patients receiving continuous renal replacement therapy or intermittent hemodialysis.Application of a Mechanistic Model to Evaluate Putative Mechanisms of Tolvaptan Drug-Induced Liver Injury and Identify Patient Susceptibility Factors.Inflammation-mediated changes in drug transporter expression/activity: implications for therapeutic drug response.Current understanding of drug disposition in kidney disease.Renohepatic crosstalk: does acute kidney injury cause liver dysfunction?The effects of acute renal failure on drug metabolism.Effects of chronic kidney disease and uremia on hepatic drug metabolism and transport.Consequences of renal failure on non-renal clearance of drugs.Oral P2Y12 Receptor Inhibitors in Hemodialysis Patients Undergoing Percutaneous Coronary Interventions: Current Knowledge and Future Directions.Effects of decreased vitamin D and accumulated uremic toxin on human CYP3A4 activity in patients with end-stage renal diseaseClinical pharmacokinetics of tyrosine kinase inhibitors: focus on pyrimidines, pyridines and pyrroles.Possibility of decrease in CYP1A2 function in patients with end-stage renal disease.Regulatory perspectives on designing pharmacokinetic studies and optimizing labeling recommendations for patients with chronic kidney disease.Effects of Chronic Renal Failure on Brain Cytochrome P450 in Rats.Inflammation down-regulates CYP3A4-catalysed drug metabolism in hemodialysis patients.
P2860
Q30524695-4C3E4CAB-D72B-45EB-BE30-E84D80CE1C31Q36410123-16941D42-093B-47AB-AA98-AD5208BE4CE6Q36634986-B2143525-99D3-4971-913C-4AE86CD44F42Q36668070-C7946872-CF71-4678-895F-A0A2F7D4AD9FQ37076544-715E1977-C585-413C-AB74-4486C3F1EF00Q37252494-BD4D38C2-B9BC-4607-9AA5-4D2B86032598Q37391009-5CDDF1A8-3DDF-435A-94D2-28E866AECF15Q37461431-CC79F83F-5043-4501-8576-58484EF4454AQ37564187-AC8EB630-37A8-4652-BA6F-92BE92950E47Q37964754-A582FFF1-88D8-41EB-ABCC-11A8AF69B861Q37974644-F087EB85-4E78-4D76-BE7D-F330BA348D81Q38107784-5BB6F266-BAE5-4BAF-932F-319590EFA901Q38145416-450346CC-34A9-48E2-8223-A284BB80C2C9Q38153196-59C186F8-58CF-4439-B627-45847AB675C6Q38214827-6EDFCD89-2DE5-4F8A-8E9B-5E6B4E662B21Q38802950-340F3477-3CE4-40E6-AF01-092A9CEBC47BQ39107147-1B9DA69A-7ACF-4AC8-B48C-76DC5CFCF50EQ43841175-2359D9C8-A4D2-4677-8EFB-B26A849AC8A6Q44095990-680DB8A9-29E6-4265-93BA-619EEF7113F9Q45815953-454C3D15-1CFE-42A5-B6BA-95C23CE72CBAQ48691291-0FA0A711-F0E0-4C9E-A576-C8044C87C709Q55439721-A0FB6848-AACA-4BA6-B32F-32BBBD35E619
P2860
Effect of hemodialysis on hepatic cytochrome P450 functional expression.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Effect of hemodialysis on hepatic cytochrome P450 functional expression.
@en
Effect of hemodialysis on hepatic cytochrome P450 functional expression.
@nl
type
label
Effect of hemodialysis on hepatic cytochrome P450 functional expression.
@en
Effect of hemodialysis on hepatic cytochrome P450 functional expression.
@nl
prefLabel
Effect of hemodialysis on hepatic cytochrome P450 functional expression.
@en
Effect of hemodialysis on hepatic cytochrome P450 functional expression.
@nl
P2093
P356
P1476
Effect of hemodialysis on hepatic cytochrome P450 functional expression.
@en
P2093
Francois A Leblond
Jean-Philippe Lafrance
Jonathan Himmelfarb
Josée Michaud
Judith Naud
Mélina Dani
Thomas D Nolin
Vincent Pichette
P304
P356
10.1254/JPHS.08042FP
P577
2008-10-09T00:00:00Z